Provided by Tiger Trade Technology Pte. Ltd.

Oric Pharmaceuticals Inc.

12.03
+0.02000.17%
Post-market: 12.030.00000.00%16:04 EDT
Volume:2.70M
Turnover:31.46M
Market Cap:1.25B
PE:-8.90
High:12.20
Open:11.87
Low:10.93
Close:12.01
52wk High:14.68
52wk Low:7.23
Shares:103.52M
Float Shares:88.69M
Volume Ratio:1.85
T/O Rate:3.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3513
EPS(LYR):-1.4747
ROE:-39.80%
ROA:-25.97%
PB:3.27
PE(LYR):-8.16

Loading ...

What ORIC Pharmaceuticals (ORIC)'s Cancer Research UK Partnership Means For Shareholders

Simply Wall St.
·
Yesterday

ORIC Pharmaceuticals (ORIC) Gains A De Risked Path As Undervalued Case Holds

Simply Wall St.
·
Oct 07

Oric Pharmaceuticals participates in a conference call with JPMorgan

TIPRANKS
·
Oct 06

Oric Pharmaceuticals, - Retains Option to Reacquire Oric-259 Rights After Phase 1/2 Data

THOMSON REUTERS
·
Oct 06

Oric® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class Cip2a-Targeted Therapy into Clinical Development

THOMSON REUTERS
·
Oct 06

ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development

GlobeNewswire
·
Oct 06

Leerink Partners Initiates ORIC Pharmaceuticals at Outperform With $26 Price Target

MT Newswires Live
·
Oct 05

Oric Pharmaceuticals, Inc. : Leerink Partners Initiates Coverage with Outperform Rating; Target Price $26

THOMSON REUTERS
·
Oct 05

Oric Pharma Director Richard A. Heyman Disposes of Common Shares Worth $86,518.47

Reuters
·
Oct 03

Oric Pharma Grants 161,550 Inducement Stock Options to New Hires Under 2022 Plan

Reuters
·
Oct 03

Oric Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Oct 03

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Oct 03

Oric Pharma CFO Dominic Piscitelli Disposes of 13,400 Common Shares Worth $181,257.78

Reuters
·
Sep 30

BTIG Initiates ORIC Pharmaceuticals at Buy With $26 Price Target

MT Newswires Live
·
Sep 23

Oric Pharma Grants 39,200 Stock Options, 6,400 RSUs to New Employees Under Inducement Plan

Reuters
·
Sep 05

Oric Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 05

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 05

Himalayas-1: Bayer and ORIC Double Down on Prostate Cancer With New Phase 3 Combo Trial

TIPRANKS
·
Sep 04

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 03

Oric Pharma CFO Dominic Piscitelli Disposes of 77,000 Common Shares Worth $1.05 Million

Reuters
·
Aug 29